Companion Animal Diagnostics Market: Growth, Size, Share, and Trends

Report Code MD 7053
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029

Overview

The global companion animal diagnostics market, valued at US$2.75 billion in 2023, is forecasted to grow at a robust CAGR of 8.8%, reaching US$2.99 billion in 2024 and an impressive US$4.55 billion by 2029. Several factors, including technological advancements in companion animal diagnostics, rising pet ownership, and increase in veterinary expenditure, drive market growth. The companion animal diagnostics market has been segmented by product, technology, animal type, application, end user and region. The companion animal diagnostics market is segmented into consumables and instruments based on product. The market is also segmented based on technology into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics and other companion animal diagnostics technologies. Based on animal type, the companion animal diagnostics market is segmented into dogs, cats, horses and other companion animals. Based on application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology and parasitology. Based on end users, the companion animal diagnostics market is segmented into diagnostics laboratories, veterinary hospitals and clinics, research institutes and universities, and home-care settings. Government regulations, such as rigorous safety standards by the FDA and favorable reimbursement policies, also support market growth. These factors facilitate an increased adoption of companion animal diagnostics in veterinary healthcare systems.

Companion Animal Diagnostics Market

Attractive Opportunities in the Companion Animal Diagnostics Market

Asia Pacific

The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.

Growth in companion animal diagnostics market is mainly driven by the increasing companion animal population.

Rising demand for pet insurance and growing animal health expenditure are key driving factors of the companion animal diagnostics market.

The Asia Pacific companion animal diagnostics market is projected to reach USD 936.7 million by 2029 during the forecast period.

The Asia Pacific market is projected to register a CAGR of 10.5% during the forecast period. China and India are emerging as major growth hotspots within the regional market.

Global Companion Animal Diagnostics Market Dynamics

DRIVER: Expansion in companion animal population

A surge in the overall companion animal population and adoption rate has been witnessed on a global scale. According to several studies, keeping a companion animal is associated with positive health benefits, such as reduced cardiac arrhythmias, normalization of blood pressure, decreased anxiety, greater psychological stability, and improved well-being. The increasing pet population is expected to drive the demand for pet care products and services, which, in turn, will support the growth of dependent industries such as companion animal diagnostics.

North America:

  • The number of households that owned a companion pet has increased from 84.9 million (an estimated 67% of US households) in 2019−2020 to 87.0 million (an estimated 70% of US households) in 2022−2023. (Source: American Pet Products Association, US)
  • The number of households-owned dogs increased from 63.4 million in 2019−2020 to 65.0 million in 2023−2024. (Source: American Pet Products Association, US)

Europe:

  • The canine population in Europe increased from 104.34 million in 2022 to 106.36 million in 2023. (Source: European Pet Food Industry Federation, FEDIAF)

Other Regions and Emerging Countries:

  • Australia has around 62% of companion animal ownership, one of the highest rates in the world. There were an estimated 29 million pets in nearly 5 million households (of 7.9 million households in the country) in 2023. (Australian Veterinary Association (AVA))
  • According to the India International Pet Trade Fair, ~600,000 pets are adopted every year in India. The number of pets in the country increased from 30 million in 2020 to 38.5 million in 2023.

The growth in companion animal ownership and the willingness to spend on the health and welfare of companion animals will support the growth of this market.

RESTRAINT: Rising pet care costs

In the last ten years, pet care costs have increased significantly. According to the American Pet Products Association (APPA) 2020 report, veterinary care is the second-highest source of spending in the pet care community. The US, for example, will spend a total of USD150.6 billion on their pets by the end of 2024; according to projections, U.S. pet spending will total almost USD 200 billion in 2030. PetMD also reported that low-to-medium pet care costs had reached USD 250 to USD 4,500 in veterinary practices, with a high-end procedure priced anywhere between USD 5,000 and USD 20,000.

According to the APPA National Pet Owners Survey 2024, the average American pet owner spent USD 1,960 on their pet(s) in 2023. The average pet dog costs USD 143 per month in 2024; cat ownership costs USD 90.50 per month, per cat. 62.4% of American households own pets; among pet owners, 66.8% own dogs. In Germany, the annual veterinary cost is ~USD 162.9 (EUR 140) per dog and USD 75.61 (EUR 65) per cat. In Japan, pet owners spend around USD 2,000–3,000 (JPY 200,000–300,000) annually on pet health. This is mainly due to the availability of advanced monitoring, diagnostic, and therapeutic procedures in veterinary practices, which, though effective, come with high price tags. Advanced products and procedures play a significant role in treatments; however, the cost of materials and equipment used in these procedures is very high. For instance, diagnostic procedures for identifying sensitivity to antimicrobials, or the presence of infection using PCR or any other advanced technologies, are costlier than the actual treatment. Hence, pet owners and veterinarians are reluctant to invest so much for diagnostic purposes.

Although the pet insurance market is expanding, the number of animals covered for treatments is still very low. As a result, animal owners generally bear most of the cost of treatments. In addition, according to the Society for Practicing Veterinary Surgeons, along with the increasing pet insurance, the cost of veterinary treatment is rising by about 12% a year. The number of consultations with veterinary specialists for pet care is another factor responsible for the increasing pet healthcare costs. Furthermore, the lower-income in this profession compared to other advanced-degree professions such as dentistry and law puts pressure on veterinary professionals to increase their fees. High pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market

 

OPPORTUNITY: Utilization of AI and ML for enhanced disease diagnosis

The use of advanced technologies, such as Artificial Intelligence (AI) and Machine Learning (ML), is only just emerging in the field of veterinary health. The utilization of these technologies aid and improve the accuracy of disease diagnosis in companion animals. Sometimes, these technologies are also combined with imaging or medical record data to analyze and interpret diagnosis patterns in animals ahead of time. For instance, Aptech Diagnostics (developed by Mars Petcare scientists) introduced its RenalTech tool to analyze and predict chronic kidney disease up to two years before the clinical diagnosis procedure. Chronic Kidney Disease (CKD) affects one-third of the cat population and is the leading cause of death in cats aged over five years. Similarly, VetAI launched its Joii App in partnership with pet insurer Animal Friends. This app uses AI and helps in the diagnosis of dermatological and inflammatory conditions while analyzing an uploaded photo of the injured animal.

However, the use of these technologies in routine clinical diagnosis is still considered to be in the nascent stage. According to studies published by the University of California and State Colorado University in 2019, utilizing machine learning on the routine CBC and serum chemistry panels aid in the diagnosis of Canine Hypoadrenocorticism (CHA) in dogs. CHA is a life-threatening condition affecting approximately 0.003% of the dog population. While other tests, such as the ACTH stimulation test, have several shortcomings (related to accuracy), the utilization of normal blood work and serum panels alongside their combination with ML enhances the accuracy of disease diagnosis. Hence, the utilization of these technologies makes for promising opportunities in the companion animal diagnostics market.

CHALLENGES: Shortage of veterinary practitioners in emerging markets

The global animal healthcare sector is significantly impacted by a shortage of skilled veterinarians and pathologists, a challenge that is especially pronounced in emerging markets such as those in Asia Pacific and Latin America. For instance, in India, the Veterinary Council of India (VCI) reported 81,938 veterinary professionals in 2023, but the country requires a minimum of 110,000-120,000 professionals to meet the standard of one veterinarian for every 5,000 animals. This shortage is also evident in countries like Brazil and China, where the demand for veterinary services far exceeds the supply of qualified professionals. This gap in supply is a key barrier to the growth of the animal healthcare industry, particularly the companion animal diagnostics market.

The limited availability of trained veterinarians restricts the adoption of advanced diagnostic solutions, which are crucial for timely and accurate diagnosis of companion animals. Furthermore, the high cost of these diagnostic tests presents an additional hurdle, particularly in developing countries where economic constraints make it difficult for many practices to afford such technologies. As a result, the lack of skilled professionals, combined with the financial barrier to adopting advanced diagnostic tools, hampers the growth potential of the animal healthcare market.

Global Companion Animal Diagnostics Market Ecosystem Analysis

This ecosystem market map represents the components of the companion animal diagnostics market, as well as defines them by demonstrating the bodies related to these elements. These include manufacturers, distributors, research & product developers, and customers.

Manufacturers include those for the whole research, design, product development, optimization, and launch of the product. Distributors include eCommerce sites linked to the organization for the marketing of animal health products and third parties. Research and product developers comprise in-house research of organizations as well as contract research organizations and contract development manufacturers, depending on which such activities or functions can be outsourced and hired. End users are where veterinary diagnostic test products have a major application. Some of the end users include Washington Animal Disease Diagnostic Laboratory, Veterinary Laboratory - University of Minnesota, Kansas State Veterinary, and Wisconsin Veterinary Laboratory.

Companion Animal Diagnostics Market
 

Consumables accounted for the largest market share in 2023.

In 2023, consumables segment accounted for the largest share of the companion animal diagnostics market due to their increasing demand for diagnostic tools and technology. This growth rate is mainly due to the emerging point-of-care solutions for quick and easy results that can be used by veterinary clinics and pet owners. The large consumable component of this kind of tool, which relies on the on-site testing followed by immediate diagnosis for pet owners or veterinary clinics, might include lateral flow assays, test kits, reagents, and imaging supplies. Lateral flow assay is a major kind of point-of-care diagnostics because of its simplicity, low cost, and speed in quick detection of different diseases and conditions for pets. Demand for consumables is further boosted by the growing emphasis on preventive care and the need for more and more tests to monitor chronic conditions, such as diabetes, kidney diseases, and cancer in pets. Besides, point-of-care instruments will also ease the burden on clinical veterinarians because tests can be done during regular visits and improved health outcomes will result due to early disease detection. The market is expected to grow substantially due to an increase in such adoption. While the technologies for diagnostics evolve further, consumables will always remain one of the key growth drivers in the companion animal diagnostics market.

Dogs held the largest share of the companion animal diagnostics market in 2023.

In 2023, dogs held largest share of the companion animal diagnostics market. Technological measures such as clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics and other companion animal diagnostics technologies have been developed for diagnosing health in canines with the acceptance of the specific needs of their health. By studying certain prevalent diseases in dogs; for example, heart disease, cancer, diabetes, and infectious conditions, diagnostic approaches have been advanced to allow early detection for better treatment approaches. Increased usage of dog diagnostic services ranging from routine health screening to expensive tests for breed-specific diseases has increased market opportunities for this application. Increasingly, people adopt dogs as family members and look at giving them almost the same priority for health care; thus, they also are now driven to see what other health aspects can be improved through veterinary diagnostics. Hence, the increased understanding of canine health along with the growing need for diagnostic solutions specific to the different niches has fairly contributed to making the dogs segment the largest in the companion animal diagnostics market.

Asia Pacific to exhibit the highest growth rate during the forecast period.

In the Asia Pacific region, the market for companion animal diagnostics is likely to grow at the highest CAGR during the forecast period; it has continued to grow mostly through rapid urbanization and increasing pet ownership indices across the region. With more individuals migrating to urban areas, veterinary clinics and diagnostic services have become more easily accessed, thereby making healthcare seeking by pet owners more comfortable. Pet health is being emphasized with this urban migration; pet owners are becoming increasingly aware of the importance of proactive health management and diagnostics opportunities such as regular check-ups and preventive care. Afflicted pet owners can now access a modern diagnostic to explore various health problems-from chronic illnesses to infections. An increase in adoption has also been observed in diagnostic tests as more people get informed about when and how to detect diseases early. It still means that pet owners spend more, especially in markets in the developing world, such as China and India, where they are spending more on superior veterinary services, including advanced diagnostics.

The companion animal diagnostics market further continues to benefit from rising numbers in the pet population, especially in urban environments, as it will create more demand for accurate and easy pet health diagnostics. The fact that urbanization, increased awareness in pet healthcare, and improving access to companion animal diagnostics are combined makes the Asia Pacific an excellent driver for companion animal diagnostics growth.

HIGHEST CAGR MARKET IN 2024-2029
CHINA FASTEST GROWING MARKET IN THE REGION
Companion Animal Diagnostics Market

Recent Developments of Companion Animal Diagnostics Market

  • Product Launch: In June 2024, IDEXX (US) launched Catalyst Pancreatic Lipase Test (Chemistry Analyzer)— The Catalyst Pancreatic Lipase test is a single-slide solution for canine & feline patients that helps identify pancreatitis.
  • Product Launch: In May 2024, Zoetis Services LLC (US) launched the Vetscan OptiCell (Analyzer)— The Vetscan OptiCell is a cartridge-based AI-powered hematology analyzer that provides advanced Complete Blood Count (CBC) analysis.
  • Acquisition: In July 2024, Mars, Incorporated (US) acquired Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Cerba Vet and ANTAGENE now complement the diagnostics portfolio in Mars Petcare’s Science & Diagnostics division.
  • Agreement: In March 2023, FUJIFILM Corporation (Japan) and Boule (Sweden) expanded its strategic agreement in Europe for veterinary solutions. FUJIFILM started to promote Boule product in three European countries in mid-2022. After successful results and excellent customer feedback FUJIFILM will now sell Boule’s veterinary hematology offering in five additional European countries.

Key Market Players

Want to explore hidden markets that can drive new revenue in Companion Animal Diagnostics Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million)
Segments covered By Product, Technology, Animal Type, Application, End User and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, GCC Countries

 

Key Questions Addressed by the Report

Which are the top industry players in the companion animal diagnostics market?
The major players in this market are IDEXX (US), Zoetis Services LLC (US), Mars, Incorporated (US), FUJIFILM Corporation (Japan), bioMérieux (France).
Which product segments have been included in the companion animal diagnostics market report?
The report contains the following product segments:
  • Consumable
  • Instruments
Which region is dominating in the companion animal diagnostics market?
In 2023, North America accounted for the largest share of the companion animal diagnostics market. North America, particularly the U.S. and Canada, has a high rate of pet ownership, leading to greater demand for companion animal diagnostics, thus dominating the market.
What are emerging trends in the companion animal diagnostics market?
Expansion in companion animal, increasing demand for pet insurance and growing animal health expenditure and growing number of veterinary practitioners are the emerging trends in the companion animal diagnostics market.
What is the total CAGR expected to be recorded for the companion animal diagnostics market during 2024-2029?
It is expected to record a CAGR of 8.8% from 2024 to 2029.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Companion Animal Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
45
EXECUTIVE SUMMARY
67
PREMIUM INSIGHTS
82
MARKET OVERVIEW
96
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    OPPORTUNITIES
    CHALLENGES 
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - DEVELOPMENT OF PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICE
    COMPLEMENTARY TECHNOLOGIES
    - WEARABLE HEALTH MONITORING DEVICES
    ADJACENT TECHNOLOGIES
    - DEVELOPMENT OF RAPID AND SENSITIVE VETERINARY DIAGNOSTIC KITS
  • 5.4 INDUSTRY TRENDS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TRADE ANALYSIS
  • 5.7 PORTER'S FIVE FORCE ANALYSIS
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.9 PATENT ANALYSIS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.11 KEY CONFERENCES & EVENTS DURING 2024-2025
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS & BUYING PROCESS
    BUYING CRITERIA
  • 5.13 ECOSYSTEM/MARKET MAP
  • 5.14 ADJACENT MARKET ANALYSIS
  • 5.15 CASE STUDY ANALYSIS
  • 5.16 IMPACT OF AI ON COMPANION ANIMAL DIAGNOSTICS MARKET
  • 5.17 UNMET NEEDS/END USER EXPECTATIONS IN COMPANION ANIMAL DIAGNOSTICS MARKET
  • 5.18 VALUE CHAIN ANALYSIS
  • 5.19 TRENDS/DISRUPTION IMPACTING CUSTOMER'S BUSINESS
  • 5.20 INVESTMENT AND FUNDING SCENARIO
COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
119
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
  • 6.3 INSTRUMENTS
COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022—2029 (USD MILLION)
145
  • 7.1 INTRODUCTION
  • 7.2 CLINICAL BIOCHEMISTRY
    CLINICAL CHEMISTRY ANALYSIS
    - REAGENTS, CLIPS, AND CARTRIDGES
    - ANALYZERS
    GLUCOSE MONITORING
    - BLOOD GLUCOSE STRIPS
    - GLUCOSE MONITORS
    - URINE GLUCOSE STRIPS
    BLOOD GAS ELECTROLYTE ANALYSIS
    - REAGENTS, CLIPS, AND CARTRIDGES
    - BLOOD GAS & ELECTROLYTE ANALYZERS
  • 7.3 IMMUNODIAGNOSTICS
    LATERAL FLOW ASSAYS
    - RAPID TESTS
    - STRIP READERS (LATERAL FLOW READERS)
    ELISA TESTS
    ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
    IMMUNOASSAY ANALYZERS
    OTHER IMMUNODIAGNOSTIC PRODUCTS
  • 7.4 HEMATOLOGY
    CARTRIDGES
    ANALYZERS
  • 7.5 URINALYSIS
    CLIPS & CARTRIDGES/PANELS
    URINE ANALYZERS
    URINE TEST STRIPS
  • 7.6 MOLECULAR DIAGNOSTICS
    POLYMERASE CHAIN REACTION TESTS
    MICROARRAYS
    OTHER MOLECULAR DIAGNOSTIC PRODUCTS
  • 7.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES
COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
187
  • 8.1 INTRODUCTION
  • 8.2 CLINICAL PATHOLOGY
  • 8.3 BACTERIOLOGY
  • 8.4 VIROLOGY
  • 8.5 PARASITOLOGY
  • 8.6 OTHER APPLICATIONS
COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
199
  • 9.1 INTRODUCTION
  • 9.2 DOGS
  • 9.3 CATS
  • 9.4 HORSES
  • 9.5 OTHER COMPANION ANIMALS
COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
226
  • 10.1 INTRODUCTION
  • 10.2 DIAGNOSTIC LABORATORIES
  • 10.3 VETERINARY HOSPITALS & CLINICS
  • 10.4 RESEARCH INSTITUTES & UNIVERSITIES
  • 10.5 HOME-CARE SETTINGS
COMPANION ANIMAL DIAGNOSTICSMARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
267
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    FRANCE
    UK
    ITALY
    SPAIN
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    JAPAN
    INDIA
    AUSTRALIA
    SOUTH KOREA
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
289
  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 12.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - TECHNOLOGY FOOTPRINT
    - PRODUCT FOOTPRINT
    - ANIMAL TYPE FOOTPRINT
    - END-USER FOOTPRINT
  • 12.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SME, 2023
    - DETAILED LIST OF KEY STARTUPS/SME
    - COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME
  • 12.6 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 12.7 MARKET SHARE ANALYSIS
  • 12.8 COMPETITIVE SITUATION AND TRENDS
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
  • 12.9 R&D ASSESSMENT OF KEY PLAYERS
  • 12.10 VALUATION AND FINANCIAL METRICS OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET
COMPANY PROFILES
309
  • 13.1 KEY PLAYERS
    IDEXX LABORATORIES, INC.
    ZOETIS INC.
    MARS
    THERMO FISHER SCIENTIFIC INC
    BIOMÉRIEUX SA
    VIRBAC
    NEOGEN CORPORATION
    FUJIFILM HOLDINGS CORPORATION
    INDICAL BIOSCIENCE GMBH
    IDVET
    RANDOX LABORATORIES, LTD.
    SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
    BIONOTE, INC
    BOULE DIAGNOSTICS AB
    EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
  • 13.2 OTHER PLAYERS
    SKYLA CORPORATION
    BIOPANDA REAGENTS LTD
    ANIPOC LTD
    EUROLYSER DIAGNOSTICA GMBH
    RING BIOTECHNOLOGY CO LTD.
    FASSISI GMBH
    ALVEDIA
    URIT MEDICAL ELECTRONICS CO., LTD.
    SWISSAVANS AG
    MEGACOR VETERINARY DIAGNOSTICS
APPENDIX
345
  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the companion animal diagnostics market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the companion animal diagnostics market. Primary sources from the demand side included veterinary hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.

A breakdown of the primary respondents for companion animal diagnostics market (supply side) market is provided below:

Companion Animal Diagnostics Market

Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 3: Other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for companion animal diagnostics market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for companion animal diagnostics market was calculated using data from three distinct sources, as will be discussed below:

Companion Animal Diagnostics Market

Data Triangulation

The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.

Approach to derive the market size and estimate market growth.

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of companion animal diagnostics. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Companion animal diagnostics are tools that utilize plasma, serum, blood, urine, feces, and tissue samples for the diagnosis of animal diseases and disorders. Companion animal diagnostics includes various test kits, tools, and instruments such as clinical chemistry analyzers, hematology analyzers, glucose monitoring systems, urine analyzers, blood gas-electrolyte analyzers, and ELISA test kits.

Stakeholders

  • Companion animal diagnostic manufacturers
  • Companion animal diagnostic distributors & suppliers
  • Companion animal R&D companies
  • Veterinary reference laboratories
  • Veterinary hospitals & clinics
  • Veterinary universities & research institutes
  • Government associations 
  • Market research & consulting firms
  • Venture capitalists & investors
  • Distributors, channel partners, and third-party suppliers

Report Objectives

  • To define, describe, and forecast the companion animal diagnostics market based on product, technology, animal type, application, end user and region.
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the companion animal diagnostics market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
  • To profile the key players and comprehensively analyze their market shares and core competencies in the companion animal diagnostics market
  • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the companion animal diagnostics market
  • To benchmark players within the companion animal diagnostics market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Previous Versions of this Report

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027

Report Code MD 7053
Published in Apr, 2022, By MarketsandMarkets™

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis), Application (Clinical Pathology, Virology, Bacteriology, Parasitology), Animal (Dog, Cat, Horse), End-User - Global Forecast to 2025

Report Code MD 7053
Published in Mar, 2020, By MarketsandMarkets™

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis), Application (Clinical Pathology, Virology, Bacteriology, Parasitology), Animal (Dog, Cat, Horse), End-User - Global Forecast to 2025

Report Code MD 7053
Published in Apr, 2019, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.
https://www.mnmks.com/demointeractivereports/display/MmZiMGYwNTIzYmY0Njc0YzFmYWVjNmUyMDkxYzYyOGE4OGI1YzBhM2IzYmUzMDAzNDM5OWQ3YzlhNWNkYzU2N10Uf0n8yuWkm3RfYWzsksV5fUZtN56kj3rb6I4SfJVaRWBySUZtn9G8vEcAfaL6JQ,,

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Companion Animal Diagnostics Market

DMCA.com Protection Status